Trajenta (Linagliptin) 5 mg is an oral medication used for the treatment of type 2 diabetes melli
Trajenta (Linagliptin) 5 mg is an oral medication used for the treatment of type 2 diabetes mellitus. It belongs to a class of drugs called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), which work by increasing the levels of incretin hormones in the body, thereby helping regulate blood sugar levels.
Primary indications:
Related products